Jefferson, BioResearch Product Faire™
Virtual Event: Thursday, August 20, 2020
Attendance is free for science professionals.
Click here for more event information
Click on the button below on 8/20
from 10am - 3pm to enter virtual event
Learn about new research techniques and technologies
Tags: Thomas Jefferson University, ThomJeff, 2020, Virtual
Researchers at Thomas Jefferson University are working hard to develop vaccines in an effort to fight some of the world’s toughest viruses and cancers. Back in 2017, Thomas Jefferson University was awarded a $30 million five-year contract over a five-year period to research safe vaccination solutions. Since then, university researchers have been developing strategies to find life changing answers to these global issues.
Read MoreTags: Thomas Jefferson University, Vaccine Technology, virus research, brain cancer treatment, biotechnology events
Cannabidiol, also known as CBD, has been a topic of interest namely for its reputation of reducing chronic pain, inflammation, and discomfort. CBD is derived from a marijuana plant with at least 112 other unique chemical compounds, referred to as cannabinoids. Along with CBD, the other most commonly known cannabinoid is tetrahydrocannabinol, or THC, well known for its psychoactive properties that leave consumers with a “high” feeling. CBD, however, doesn’t produce these same “high” affects, so its addictive risk substantially decreases, therefore increasing its appeal in the medical field. #CBD #cannbidiol #research #funding
Read MoreTags: University of Pittsburgh, Thomas Jefferson University, UCSD research, UC Berkeley, BioResearch Product Faire™, cbd, UCLA Events, cannabidiol, CU Anschutz
Thomas Jefferson receives over 40 million in National Institute of Health (NIH) research funding each year. One of the projects supported by the NIH since 2011 has been an investigation into DNA viruses. This study recently yielded new insight into the two states of a viral protein and revealed its function as a DNA-sensor. This finding may serve as a road map for developing anti-viral therapy for pathogenic DNA viruses.
Read More
Tags: Pennsylvania, Thomas Jefferson University, NIH funded Research Projects, Research Funding, Northeast Region, ThomJeff, TJU, viruses
Each year, The Sidney Kimmel Cancer Center (SKCC) at Jefferson University Hospital receives approximately $72 million in grants for cancer research from organizations such as Susan Komen for the Cure. This year the SKCC received a $3 million donation from Esperanza and David Neu in order to establish the Neu Center for Supportive Medicine and Cancer Survivorship. The purpose of the Neu Center is to serve as a comprehensive resource for psycho-social care and research.
Read MoreTags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, NIH funded Research Projects, Philadelphia, PA, NIH funding, Cancer Center, ThomJeff, cancer research funding, BioResearch Product Faire, NIH awards 2017, 2017 research funding
A $3 million philanthropic gift was recently given to The Institute of Emerging Health Professions at Thomas Jefferson University. The new funding will support its Center for Medical Cannabis Education and Research, where researchers will study the therapeutic potential of a wide range of cannabinoids. Thomas Jefferson is the first major health sciences university in the nation to establish such a center.
Read More
Tags: Pennsylvania, Thomas Jefferson University, new research funding, Northeast Region, New research center, TJU
Lung cancer is one of the most common types of cancers and is responsible for the most cancer deaths each year. Due to its prevalence, lung cancer is a point of study for many researchers around the world. Just this year, researchers from the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have discovered that the gene Nitrilase 1 (Nit1) plays a large role in the proliferation of cancer cells.
Read MoreTags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, Philadelphia, PA, ThomJeff, 2016, BioResearch Product Faire, Nitrilase 1, lung cancer, Nit1
Parkinson's Disease is a devastating neurodegenerative disease that affects people's motor functions. As of today, there are no cures for Parkinson's Disease, and treatments are only able to alleviate symptoms. Researchers across the nation are heavily studying the disease, with the goal of learning more about the onset and progress of the disease to help scientists develop treatment methods.
Tags: Northeast, Thomas Jefferson University, Parkinson's Disease Research, Philadelphia, PA, ThomJeff, 2016, Parkinson's Disease, BioResearch Product Faire, GM1 ganglioside
Imagine finally getting a knee replacement after dealing with years of crippling pain, only to develop a staph, or MRSA, infection at the surgery site. Not only is the pain still present, perhaps even worse, but rest of the body’s health is now at risk as well.
Tags: Pennsylvania, Thomas Jefferson University, 2015, Philadelphia, BioResearch Product Faire Event, PA, NIH funding, NIH grants, ThomJeff
MicroRNA (miRNA) play an important role in controlling different processes that occur in cells through gene regulation. These small molecules are able to regulate many cellular processes by reducing target amounts in the cells. There are more than 1,900 locations in the human genome that are known to produce these miRNA molecules.
Bioresearchers at Thomas Jefferson University in Philadelphia recently uncovered 3,400 new locations in the human genome that also produce miRNA molecules, offering up more options for further research into the relationship between miRNA and disease.
Read MoreTags: Northeast, Thomas Jefferson University, 2015, Philadelphia, BioResearch Product Faire Event, PA, ThomJeff, miRNA, human genome
